Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de George Yancopoulos
Age : 61
Public asset : 819,349,459 USD
Country of residence : Unknown
Linked companies : Regeneron Pharmaceuticals, Inc.

Biography of George Yancopoulos 
Currently, George Damis Yancopoulos occupies the position of Co-President, Director & Chief Scientific Officer at Regeneron Pharmaceuticals, Inc. and President at Regeneron Research Laboratories (a subsidiary of Regeneron Pharmaceuticals, Inc.). Dr. Yancopoulos is also on the board of Cold Spring Harbor Laboratory, Inc. and Member of National Academy of Sciences. He received a doctorate from The Trustees of Columbia University in The City of New York.


Current positions of George Yancopoulos 
Holdings of George Yancopoulos 
George Yancopoulos : Personal Network 
Most Read News 
01/18ELON MUSK : Tesla investors urge judge to order Musk repay $13 billion for SolarCity deal
RE
01/11JAMIE DIMON : JPMorgan's Dimon says consumer loan growth may take 6-9 months to return to normal
RE
01/13JACK DORSEY : Jack Dorsey's Block to build an open bitcoin mining system
RE
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
RE
01/20ALAN JOPE : Unilever strategy under scrutiny after short-lived GSK skirmish
RE
01/10BRUNELLO CUCINELLI : Luxury group Cucinelli posts 31% sales jump in 2021
RE
01/11CATHIE WOOD : ARK's Wood turns focus to deflation, 'stay connected' stocks
RE
01/12MARTIN SORRELL : Sorrell's S4 says trading well ahead of guidance
RE
01/13AMANCIO ORTEGA : Inditex founder Amancio Ortega buys Toronto's Royal Bank Plaza for $916 mln
RE
01/17ELON MUSK : Top Energy News of the Day
DJ
More news


© 2022 People and Ownership :   
George Yancopoulos : Connections 


Latest news about George Yancopoulos 
2021Regeneron Study Shows COVID-19 Drug Cocktail Almost 82% Effective in Preventing Infection Over 8 Months
MT
2021Regeneron's antibody drug shows protection against COVID-19 for up to 8 months
RE
2021Regeneron's antibody drug shows protection against COVID-19 for up to 8 months
RE
2021REGENERON PHARMACEUTICALS : Reports Mid-Stage Data of High-Dose Aflibercept in Wet Age-Related Macular Degeneration
MT
2021REGENERON PHARMACEUTICALS : Significant Insider Sales in Shares of Regeneron Pharmaceuticals (REGN) Extends the Selling Trend of Last Quarter
MT
2021INSIDER TRENDS : Insider Disposition at Regeneron Pharmaceuticals Slowing 90-Days of Buying
MT
2021REGENERON PHARMACEUTICALS : Phase 3 Study Shows REGEN-COV Reduces Death Risk in Certain Hospitalized COVID-19 Patients
MT
More news